These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2454366

  • 1. Studies on the mode of vasodilating action of carvedilol.
    Sponer G, Strein K, Müller-Beckmann B, Bartsch W.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
    [Abstract] [Full Text] [Related]

  • 2. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H, Kanda A, Hubo H, Tanaka M.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties.
    Strein K, Sponer G, Müller-Beckmann B, Bartsch W.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S33-41. PubMed ID: 2454365
    [Abstract] [Full Text] [Related]

  • 4. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
    Hashimoto H, Tanaka M, Kanda A, Akashi A.
    Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
    [Abstract] [Full Text] [Related]

  • 6. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ, Gellai M, Ruffolo RR.
    Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
    [Abstract] [Full Text] [Related]

  • 7. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR.
    Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
    Palluk R, Hoefke W.
    Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
    [Abstract] [Full Text] [Related]

  • 9. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
    Bartsch W, Sponer G, Strein K, Böhm E, Hooper RG.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 11():S49-51. PubMed ID: 2454367
    [Abstract] [Full Text] [Related]

  • 12. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M, Takasuna K, Tamura K, Yamaguchi K, Maekawa K, Yamada S, Iwasaki S, Yoshida M, Nomura M, Taguchi K.
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [Abstract] [Full Text] [Related]

  • 13. Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery.
    Hattori Y, Nakaya H, Endou M, Nakao Y, Kanno M.
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):572-9. PubMed ID: 2470994
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C, Cattaneo BM, Seravalle G, Carugo S, Mangoni AA, Grassi G, Zanchetti A, Mancia G.
    J Cardiovasc Pharmacol; 1992 Apr; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [Abstract] [Full Text] [Related]

  • 17. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B, Bompart F, Graham BR, Liu JB, Prichard BN.
    Drugs; 1988 Apr; 36 Suppl 6():37-47. PubMed ID: 2908303
    [Abstract] [Full Text] [Related]

  • 18. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
    Tanaka M, Masumura H, Tanaka S, Akashi A.
    J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 11():S52-7. PubMed ID: 2454368
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y, Nakamura M, Shimizu S, Shirasawa Y, Fujii M.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [Abstract] [Full Text] [Related]

  • 20. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.